Anavex Life Sciences Corp (AVXL)

[ignatiusrielly35]

This doesn’t make sense to me. Why, and how, would the CHMP conclude, before the application is completed/accepted, that the substantive results are not good enough? Any perceived deficiencies in the application, it would seem to me, would be procedural/technical as opposed to substantive, no?

Barring some clearly fatal flaw in the trial methodology or the validity of the data, or a fatal error in the statistical analysis, the agency will accept the application and decide based on substance, right?